| |
 |
|
Mike Williams - Interim President
Mike Williams is a well-regarded and highly respected strategic leader who is known as a consensus builder and who brings more than 25 years of management and financial experience to his clients. As interim president of Susan G. Komen for the Cure®, Williams will ensure the alignment of strategic plans, organizational structure and financial planning to maximize success.
Read more
|
| |
|
|
Mark E. Nadolny - Chief Financial Officer
As chief financial officer for Susan G. Komen for the Cure®, Mark E. Nadolny is responsible for all financial matters affecting the world’s largest breast cancer organization. Since inception, Komen for the Cure has invested nearly $1.5 billion, making it the world’s largest source of private funds for breast cancer research and community programs involving awareness, education, screening, treatment and direct services for breast cancer.
Read more
|
 |
|
Justin Ricketts - Chief Information Officer
As chief information officer at Susan G. Komen for the Cure®, Justin Ricketts provides the technology vision and leadership in the development and implementation of enterprise-wide IT programs. Ricketts partners with decision makers in all departments to identify and implement technology solutions that reduce costs and accelerate science.
Read more
|
| |
 |
|
Emily Callahan - Senior Vice President, Global Marketing & Networks
As senior vice president of global marketing and networks for Susan G. Komen for the Cure®, Emily Callahan oversees the organization’s marketing function including communications, public relations, interactive media, event-planning, brand marketing and advertising. In addition, she also guides Komen’s ongoing efforts to identify, cultivate and strengthen relationships with key constituents of the organization, such as top-tier media outlets, corporate partners, major donors, grant recipients and celebrities.
Read more
|
| |
 |
|
Jennifer M. Luray - Senior Vice President, Government Affairs and Public Policy
As senior vice president of government affairs and public policy for Susan G. Komen for the Cure® and president of our sister organization, the Susan G. Komen for the Cure® Advocacy Alliance, Jennifer Luray is the leader of Komen for the Cure’s Washington, D.C. office, and serves as the organization’s top liaison to the White House, Capitol Hill, and key policymakers on domestic and global health issues. Under her leadership, the 501c4 Komen Advocacy Alliance advocates at all levels of government for increased funding for research and access to potentially life-saving screening and treatment programs.
Read more
|
 |
|
Katrina McGhee - Senior Vice President, Global Business & Partnerships
As senior vice president of global business and partnerships for Susan G. Komen for the Cure®, Katrina McGhee oversees the organization’s cause marketing programs and corporate sponsorships in addition to leading and developing global efforts to engage new audiences with the organization. She provides strategic direction for more than 200 corporate relationships currently in the Komen for the Cure portfolio and enjoys sharing her knowledge with others by serving as a speaker for national organizations such as the Promotions Marketing Association, Cause Marketing Forum and the Event and Arena Marketers Association.
Read more
|
 |
|
Elizabeth Thompson - Senior Vice President, Medical & Scientific Affairs
As senior vice president, medical and scientific affairs for Susan G. Komen for the Cure®, Elizabeth “Liz” Thompson is responsible for leading Komen’s extensive health sciences team and engaging Komen in areas such as grants, community health programs, scientific advisory, public policy, advocacy and education. Thompson works closely with Komen’s chief scientific advisor, Dr. Eric Winer, and the organization’s Scientific Advisory Board. She also participates with external committees, boards or review panels and represents Komen’s mission, position and perspective.
Read more
|
 |
|
Diana Rowden - Survivorship & Outcomes Vice President
As survivorship and outcomes vice president for Susan G. Komen for the Cure®, Diana Rowden brings breadth and depth to her position, having served in a variety of leadership roles at Komen for the Cure for more than 15 years. Previously, Rowden was vice president of Komen’s Affiliate Network and oversaw its more than 120 Affiliates. She also led Komen's extensive health sciences division as vice president, overseeing the organization’s research grant strategy, community health outreach and education. She worked closely with the chief scientific advisor, Dr. Eric Winer, and Komen’s Scientific Advisory Board to examine medical and public health policy.
Read more
|
 |
|
Marianne Alciati, Ph. D. - Research and Scientific Affairs Vice President
As research and scientific affairs vice president for Susan G. Komen for the Cure®, Marianne Alciati is responsible for Komen for the Cure's significant portfolio of research investments as well as engagement with the scientific community. Alciati and her team work to identify opportunites for collaboration and innovation, further common research objectives, and inform public policy and advocacy efforts.
Read more
|
| |
.jpg "Nancy Macgregor, Managing Director, Affiliate Strategy and Planning") |
|
Nancy Macgregor - Vice President, Global Networks
Nancy Macgregor has been with Susan G. Komen for the Cure® for much of its history. As vice president, global networks, Macgregor collaborates with other Komen leadership members to develop, implement and evaluate strategies to build and sustain the capacity of the Komen Affiliate Network, which includes more than 120 Affiliates in the U.S. and three globally. Macgregor guides development and evaluation of pilot projects, benchmarks, standards of excellence and supporting resources to build and sustain the Affiliates’ capacity to fulfill Komen’s promise to save lives and end breast cancer forever. She also plays a key role in connecting Komen for the Cure’s U.S. Affiliate strategy to its international Affiliate strategy.
Read more
|
| |
 |
|
Susan Carter Johns - Strategic Relationships Vice President
As strategic relationships vice president at Susan G. Komen for the Cure®, Susan Carter Johns focuses on organizational effectiveness. Serving as executive champion and steward of Komen’s culture, she works closely with the human resources and internal communications teams, as well as manages the development function of the world’s largest private funder of breast cancer research outside of the U.S. government. She also serves as primary liaison to Komen’s founder and CEO, Ambassador Nancy G. Brinker.
Read more
|
| |
 |
|
Jonathan Blum - General Counsel
As general counsel for Susan G. Komen for the Cure®, the world’s largest grassroots network of breast cancer survivors and activists, Jonathan Blum is responsible for overseeing the organization’s legal department, which includes guiding the international headquarters and its more than 120 Affiliates in securing responsible partnerships with corporations and partners. He has lead functional responsibility for legal, insurance and internal audit matters.
Read more
|
| |
